Changes in diet and lifestyle factors are frequently recommended for persons with irritable bowel syndrome (IBS). It is unknown whether these recommendations alter the gut microbiome and/or whether baseline microbiome predicts improvement in symptoms and quality of life following treatment. Therefore, the purpose of this study was to explore if baseline gut microbiome composition predicted response to a Comprehensive Self-Management (CSM) intervention and if the intervention resulted in a different gut microbiome composition compared to usual care.
Methods:
Individuals aged 18–70 years with IBS symptoms ≥6 months were recruited using convenience sampling. Individuals were excluded if medication use or comorbidities would influence symptoms or microbiome. Participants completed a baseline assessment and were randomized into the eight-session CSM intervention which included dietary education and cognitive behavioral therapy versus usual care. Questionnaires included demographics, quality of life, and symptom diaries. Fecal samples were collected at baseline and 3-month post-randomization for 16S rRNA-based microbiome analysis.
Results:
Within the CSM intervention group (n = 30), Shannon diversity, richness, and beta diversity measures at baseline did not predict benefit from the CSM intervention at 3 months, as measured by change in abdominal pain and quality of life. Based on both alpha and beta diversity, the change from baseline to follow-up microbiome bacterial taxa did not differ between CSM (n = 25) and usual care (n = 25).
Conclusions and Inferences:
Baseline microbiome does not predict symptom improvement with CSM intervention. We do not find evidence that the CSM intervention influences gut microbiome diversity or composition over the course of 3 months.
AllenA. P.HutchW.BorreY. E.KennedyP. J.TemkoA.BoylanG.MurphyE.CryanJ. F.DinanT. G.ClarkeG. (2016). Bifidobacterium longum 1714 as a translational psychobiotic: Modulation of stress, electrophysiology and neurocognition in healthy volunteers. Translational Psychiatry, 6(11), e939–e939. https://doi.org/10.1038/tp.2016.191
2.
BennetS. M. P.BohnL.StorsrudS.LiljeboT.CollinL.LindforsP.TornblomH.OhmanL.SimrenM. (2018). Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs. Gut, 67(5), 872–881. https://doi.org/10.1136/gutjnl-2016-313128
3.
BennetS. M. P.OhmanL.SimrenM. (2015). Gut microbiota as potential orchestrators of irritable bowel syndrome. Gut Liver, 9(3), 318–331. https://doi.org/10.5009/gnl14344
4.
BarneyP.WeismanP.JarrettM.LevyR. L.HeitkemperM. (2010). Master your IBS: An 8-week plan proven to control the symptoms of irritable bowel syndrome. AGA Press.
5.
BiesiekierskiJ. R.JalankaJ.StaudacherH. M. (2019). Can gut microbiota composition predict response to dietary treatments?Nutrients, 11(5), 1134. https://doi.org/10.3390/nu11051134
6.
BijkerkC. J.de WitN. J.MurisJ. W.WhorwellP. J.KnottnerusJ. A.HoesA. W. (2009). Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. BMJ, 339, b3154. https://doi.org/10.1136/bmj.b3154
7.
BohnL.StorsrudS.LiljeboT.CollinL.LindforsP.TornblomH.SimrenM. (2015). Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: A randomized controlled trial. Gastroenterology, 149(6), 1399–1407. e1392. https://doi.org/10.1053/j.gastro.2015.07.054
8.
BonnertM.OlénO.LalouniM.BenningaM. A.BottaiM.EngelbrektssonJ.HedmanE.LenhardF.MelinB.SimrénM.VigerlandS.SerlachiusE.LjótssonB. (2017). Internet-delivered cognitive behavior therapy for adolescents with irritable bowel syndrome: A randomized controlled trial. The American Journal of Gastroenterology, 112(1), 152–162. https://doi.org/10.1038/ajg.2016.503
9.
ChongP. P.ChinV. K.LooiC. Y.WongW. F.MadhavanP.YongV. C. (2019). The microbiome and irritable bowel syndrome—A review on the pathophysiology, current research and future therapy. Frontiers in Microbiology, 10, 1136–1136. https://doi.org/10.3389/fmicb.2019.01136
10.
ChumpitaziB. P.CopeJ. L.HollisterE. B.TsaiC. M.McMeansA. R.LunaR. A.VersalovicJ.ShulmanR. J. (2015) Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 42(4), 418–427. https://doi.org/10.1111/apt.13286
11.
DoshiJ. A.CaiQ.BuonoJ. L.SpaldingW. M.SaroccoP.TanH.StephensonJ. J.CarsonR. T. (2014). Economic burden of irritable bowel syndrome with constipation: A retrospective analysis of health care costs in a commercially insured population. Journal of Managed Care & Specialty Pharmacy, 20(4), 382–390. https://doi.org/10.18553/jmcp.2014.20.4.382
12.
DrossmanD. A. (2016). Functional gastrointestinal disorders: History, pathophysiology, clinical features and Rome IV. Gastroenterology, 150(6), 1262–1279. https://doi.org/10.1053/j.gastro.2016.02.032
13.
EverittH. A.LandauS.O’ReillyG.SibelliA.HughesS.WindgassenS.HollandR.LittleP.McCroneP.BishopF.GoldsmithK.ColemanN.LoganR.ChalderT.Moss-MorrisR. (2019). Assessing telephone-delivered cognitive-behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): A multicentre randomised trial. Gut, 68(9), 1613–1623. https://doi.org/10.1136/gutjnl-2018-317805
14.
HahnB. A.KirchdoerferL. J.FullertonS.MayerE. (1997). Evaluation of a new quality of life questionnaire for patients with irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 11(3), 547–552. https://doi.org/10.1046/j.1365-2036.1997.00168.x
15.
HeitkemperM. M.JarrettM. E.LevyR. L.CainK. C.BurrR. L.FeldA.BarneyP.WeismanP. (2004). Self-management for women with irritable bowel syndrome. Clinical Gastroenterology and Hepatology, 2(7), 585–596.
16.
HeymN.HeasmanB. C.HunterK.BlancoS. R.WangG. Y.SiegertR.CleareA.GibsonG. R.KumariV.SumichA. L. (2019). The role of microbiota and inflammation in self-judgement and empathy: Implications for understanding the brain-gut-microbiome axis in depression. Psychopharmacology (Berl), 236(5), 1459–1470. https://doi.org/10.1007/s00213-019-05230-2
17.
HollisterE. B.CainK. C.ShulmanR. J.JarrettM. E.BurrR. L.KoC.ZiaJ.HanC. J.HeitkemperM. M. (2020). Relationships of microbiome markers with extraintestinal, psychological distress and gastrointestinal symptoms, and quality of life in women with irritable bowel syndrome. Journal of Clinical Gastroenterology, 54(2), 175–183. https://doi.org/10.1097/mcg.0000000000001107
18.
HsuehH.-F.JarrettM. E.CainK. C.BurrR. L.DeechakawanW.HeitkemperM. M. (2011). Does a self-management program change dietary intake in adults with irritable bowel syndrome?Gastroenterology Nursing, 34(2), 108–116. https://doi.org/10.1097/SGA.0b013e31821092e8
19.
HuoR.ZengB.ZengL.ChengK.LiB.LuoY.WangH.ZhouC.FangL.LiW.NiuR.WeiH.XieP. (2017). Microbiota modulate anxiety-like behavior and endocrine abnormalities in hypothalamic-pituitary-adrenal axis. Frontiers in Cellular and Infection Microbiology, 7, 489. https://doi.org/10.3389/fcimb.2017.00489
20.
JacobsJ. P.LacknerJ. M.LagishettyV.GudleskiG. D.FirthR. S.TillischK.NaliboffB. D.LabusJ. S.MayerE. A. (2018). 915—intestinal microbiota predict response to cognitive behavioral therapy for irritable bowel syndrome. Gastroenterology, 154(6), S–181. https://doi.org/10.1016/S0016-5085(18)31017-5
21.
JarrettM. E.CainK. C.BarneyP. G.BurrR. L.NaliboffB. D.ShulmanR.ZiaJ.HeitkemperM. M. (2016). Balance of autonomic nervous system predicts who benefits from a self-management intervention program for irritable bowel syndrome. Journal of Neurogastroenterology and Motility, 22(1), 102–111. https://doi.org/10.5056/jnm15067
22.
JarrettM. E.CainK. C.BurrR. L.HertigV. L.RosenS. N.HeitkemperM. M. (2009). Comprehensive self-management for irritable bowel syndrome: Randomized trial of in-person vs. combined in-person and telephone sessions. The American Journal of Gastroenterology, 104(12), 3004–3014. https://doi.org/10.1038/ajg.2009.479
23.
JeffersonA.AdolphusK. (2019). The effects of intact cereal grain fibers, including wheat bran on the gut microbiota composition of healthy adults: A systematic review. Frontiers in Nutrition, 6, 33. https://doi.org/10.3389/fnut.2019.00033
24.
JuT.NaliboffB. D.ShihW.PressonA. P.LiuC.GuptaA.MayerE. A.ChangL. (2020). Risk and protective factors related to early adverse life events in irritable bowel syndrome. Journal of Clinical Gastroenterology, 54(1), 63–69. https://doi.org/10.1097/mcg.0000000000001153
25.
LabusJ.GuptaA.GillH. K.PosserudI.MayerM.RaeenH.BolusR.SimrenM.NaliboffB. D.MayerE. A. (2013). Randomised clinical trial: Symptoms of the irritable bowel syndrome are improved by a psycho-education group intervention. Alimentary Pharmacology & Therapeutics, 37(3), 304–315. https://doi.org/10.1111/apt.12171
26.
LacknerJ. M.JaccardJ.KeeferL.BrennerD. M.FirthR. S.GudleskiG. D.HamiltonF. A.KatzL. A.KrasnerS. S.MaC.-X.RadziwonC. D.SitrinM. D. (2018). Improvement in gastrointestinal symptoms after cognitive behavior therapy for refractory irritable bowel syndrome. Gastroenterology, 155(1), 47–57. https://doi.org/10.1053/j.gastro.2018.03.063
27.
LiuH. N.WuH.ChenY. Z.ChenY. J.ShenX. Z.LiuT. T. (2017). Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis. Digestive and Liver Disease, 49(4), 331–337. https://doi.org/10.1016/j.dld.2017.01.142
28.
LunaR. A.OezguenN.BalderasM.VenkatachalamA.RungeJ. K.VersalovicJ.Veenstra-VanderWeeleJ.AndersonG. M.SavidgeT.WilliamsK. C. (2017). Distinct microbiome-neuroimmune signatures correlate with functional abdominal pain in children with autism spectrum disorder. Cellular and Molecular Gastroenterology and Hepatology, 3(2), 218–230. https://doi.org/10.1016/j.jcmgh.2016.11.008
29.
MariA.Abu BakerF.MahamidM.SbeitW.KhouryT. (2020). The evolving role of gut microbiota in the management of irritable bowel syndrome: An overview of the current knowledge. Journal of Clinical Medicine, 9(3). https://doi.org/10.3390/jcm9030685
MoserG.FournierC.PeterJ. (2018). Intestinal microbiome-gut-brain axis and irritable bowel syndrome. Wiener medizinische Wochenschrift (1946), 168(3–4), 62–66. https://doi.org/10.1007/s10354-017-0592-0
32.
MukhtarK.NawazH.AbidS. (2019). Functional gastrointestinal disorders and gut-brain axis: What does the future hold?World Journal of Gastroenterology, 25(5), 552–566. https://doi.org/10.3748/wjg.v25.i5.552
33.
O’MahonyS. M.ClarkeG.BorreY. E.DinanT. G.CryanJ. F. (2015). Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behavioural Brain Research, 277, 32–48. https://doi.org/10.1016/j.bbr.2014.07.027
PlantingaA. M.ChenJ.JenqR. R.WuM. C. (2019). PLDIST: Ecological dissimilarities for paired and longitudinal microbiome association analysis. Bioinformatics, 35(19), 3567–3575. https://doi.org/10.1093/bioinformatics/btz120
36.
RingströmG.StörsrudS.SimrénM. (2012). A comparison of a short nurse-based and a long multidisciplinary version of structured patient education in irritable bowel syndrome. European Journal of Gastroenterology & Hepatology, 24(8), 950–957. https://doi.org/10.1097/MEG.0b013e328354f41f
37.
Rodiño-JaneiroB. K.VicarioM.Alonso-CotonerC.Pascua-GarcíaR.SantosJ. (2018). A review of microbiota and irritable bowel syndrome: Future in therapies. Advances in Therapy, 35(3), 289–310. https://doi.org/10.1007/s12325-018-0673-5
38.
SchnorrS. L.BachnerH. A. (2016). Integrative therapies in anxiety treatment with special emphasis on the gut microbiome. The Yale Journal of Biology and Medicine, 89(3), 397–422.
39.
ShulmanR. J.HollisterE. B.CainK.CzyzewskiD. I.SelfM. M.WeidlerE. M.DevarajS.LunaR. A.VersalovicJ.HeitkemperM. (2017). Psyllium fiber reduces abdominal pain in children with irritable bowel syndrome in a randomized, double-blind trial. Clinical Gastroenterology and Hepatology, 15(5), 712–719. e714. https://doi.org/10.1016/j.cgh.2016.03.045
40.
SimpsonC. A.MuA.HaslamN.SchwartzO. S.SimmonsJ. G. (2020). Feeling down? A systematic review of the gut microbiota in anxiety/depression and irritable bowel syndrome. Journal of Affective Disorders, 266, 429–446. https://doi.org/10.1016/j.jad.2020.01.124
41.
SinghJ.MetraniR.ShivanagoudraS. R.JayaprakashaG. K.PatilB. S. (2019). Review on bile acids: Effects of the gut microbiome, interactions with dietary fiber, and alterations in the bioaccessibility of bioactive compounds. Journal of Agricultural and Food Chemistry, 67(33), 9124–9138. https://doi.org/10.1021/acs.jafc.8b07306
42.
SperberA. D.DumitrascuD.FukudoS.GersonC.GhoshalU. C.GweeK. A.HunginA. P. S.KangJ.-Y.MinhuC.SchmulsonM.BolotinA.FrigerM.FreudT.WhiteheadW. (2017). The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: A Rome Foundation working team literature review. Gut, 66(6), 1075. https://doi.org/10.1136/gutjnl-2015-311240
43.
TillischK.MayerE. A.GuptaA.GillZ.BrazeillesR.Le NevéB.van Hylckama VliegJ. E. T.GuyonnetD.DerrienM.LabusJ. S. (2017). Brain structure and response to emotional stimuli as related to gut microbial profiles in healthy women. Psychosomatic Medicine, 79(8), 905–913. https://doi.org/10.1097/psy.0000000000000493
44.
Valles-ColomerM.FalonyG.DarziY.TigchelaarE. F.WangJ.TitoR. Y.SchiweckC.KurilshikovA.JoossensM.WijmengaC.ClaesS.Van OudenhoveL.ZhernakovaA.Vieira-SilvaS.RaesJ. (2019). The neuroactive potential of the human gut microbiota in quality of life and depression. Nature Microbiology, 4(4), 623–632. https://doi.org/10.1038/s41564-018-0337-x
45.
van de WouwM.BoehmeM.LyteJ. M.WileyN.StrainC.O’SullivanO.ClarkeG.StantonC.DinanT. G.CryanJ. F. (2018). Short-chain fatty acids: Microbial metabolites that alleviate stress-induced brain-gut axis alterations. The Journal of Physiology, 596(20), 4923–4944. https://doi.org/10.1113/jp276431
VodičkaM.ErgangP.HrnčířT.MikuleckáA.KvapilováP.VagnerováK.ŠestákováB.FajstováA.HermanováP.HudcovicT.KozákováH.PáchaJ. (2018). Microbiota affects the expression of genes involved in HPA axis regulation and local metabolism of glucocorticoids in chronic psychosocial stress. Brain, Behavior, and Immunity, 73, 615–624. https://doi.org/10.1016/j.bbi.2018.07.007
48.
WangL.AlammarN.SinghR.NanavatiJ.SongY.ChaudharyR.MullinG. E. (2020). Gut microbial dysbiosis in the irritable bowel syndrome: A systematic review and meta-analysis of case-control studies. Journal of the Academy of Nutrition and Dietetics, 120(4), 565–586. https://doi.org/10.1016/j.jand.2019.05.015
49.
WindgassenS.Moss-MorrisR.ChilcotJ.SibelliA.GoldsmithK.ChalderT. (2017). The journey between brain and gut: A systematic review of psychological mechanisms of treatment effect in irritable bowel syndrome. British Journal of Health Psychology, 22(4), 701–736. https://doi.org/10.1111/bjhp.12250
50.
WindgassenS.Moss-MorrisR.GoldsmithK.ChalderT. (2019). Key mechanisms of cognitive behavioural therapy in irritable bowel syndrome: The importance of gastrointestinal related cognitions, behaviours and general anxiety. Journal of Psychosomatic Research, 118, 73–82. https://doi.org/10.1016/j.jpsychores.2018.11.013
51.
WuG. D.ChenJ.HoffmannC.BittingerK.ChenY.-Y.KeilbaughS. A.BewtraM.KnightsD.WaltersW. A.KnightR.SinhaR.GilroyE.GuptaK.BaldassanoR.NesselL.LiH.BushmanF. D.LewisJ. D. (2011). Linking long-term dietary patterns with gut microbial enterotypes. Science (New York, N.Y.), 334(6052), 105–108. https://doi.org/10.1126/science.1208344
52.
YoshinoA.OkamotoY.OkadaG.TakamuraM.IchikawaN.ShibasakiC.YokoyamaS.DoiM.JinninR.YamashitaH.HorikoshiM.YamawakiS. (2018). Changes in resting-state brain networks after cognitive-behavioral therapy for chronic pain. Psychological Medicine, 48(7), 1148–1156. https://doi.org/10.1017/s0033291717002598
53.
ZhaoN.ChenJ.CarrollI. M.Ringel-KulkaT.EpsteinM. P.ZhouH.ZhouJ. J.RingelY.LiH.WuM. C. (2015). Testing in microbiome-profiling studies with MiRKAT, the microbiome regression-based kernel association test. American Journal of Human Genetics, 96(5), 797–807. https://doi.org/10.1016/j.ajhg.2015.04.003
54.
ZhuS.JiangY.XuK.CuiM.YeW.ZhaoG.JinL.ChenX. (2020). The progress of gut microbiome research related to brain disorders. Journal of Neuroinflammation, 17(1), 25. https://doi.org/10.1186/s12974-020-1705-z
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
